ENLITIC • Ownership 25% undiluted, 1 board seat • Collaboration...

ENLITIC
•
Ownership 25% undiluted, 1 board seat
•
Collaboration agreement in China
•
Australian rights to use Enlitic as part of clinical partnership
•
> 18 months of cash runway
•
ENLITIC continues to make major breakthroughs in applying Deep Learning to DI
•
Chest X-ray Triage -CT Lung Cancer detection –Natural Language Processing (NLP) –Mammography –Head CT
•
Customers conducting real time blind data testing validating products efficacy
•
Clinical study for early stage lung cancer detection in progress -U.S. research institution
•
Leading medical data inventory from international sources
•
Foundational patent applications in medical deep learning filed
•
Incremental multi-jurisdictional regulatory approval strategy in motion
•
1M euro CUBE challenge prize won as judged by Apple Founder Steve Wozniak for developing technology with the greatest potential to positively impact the world
•
Engaging with clinical providers on secondary review and triage products expected to fully deploy over the next 6 -12 months in Japan, Canada and Australia
•
PaiyiPaiMOU not progressed
•
Working with a large, Toronto-based hospital network on a pilot project to read and triage in-patient head CTs to prioritize those with signs of strokes, intracranial haemorrhage, and venous thrombosis
•
Working with several large pharmaceutical companies using deep learning around DI to improve outcomes of drug clinical studies
Very interesting @spid81

Champee